Join Growin Stock Community!

優盛4121.TW Overview

TW StockBiotech. & Medical
(No presentation for 4121)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

優盛（4121）Overall Performance

優盛（4121）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

優盛（4121） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

優盛（4121）Key Information

優盛（4121）Profile

Rossmax International Ltd. develops and supplies healthcare products and solutions. The company offers body fat monitors and scales that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds of an animal or human body; handheld pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact telephoto thermometers used to measure human body temperature; and blood glucose monitoring system, a medical device for determining the approximate concentration of glucose in the blood. It also provides nebulizer, a drug delivery device used to administer medication in the form of a mist; suction unit, a machine used to remove mucus and other bodily fluids; aero spacer, a device used to increase the ease of administering aerosolized medication; peak flow meter, a device used to monitor a person's ability to breathe out air; heating pads used for therapy; and anti-decubitus mattresses. In addition, the company operates Rossmax healthstyle app, which allows customers to monitor blood pressure, blood glucose, SpO2, weight, and temperature through a single app. It provides healthcare products in the fields of cardiovascular, diabetes, respiratory, fever, and wound healing diseases, as well as thermometers, scales, and nebulizers for kidshealth. The company also exports its products. It operates in Taiwan, Italy, Brazil. Mainland China, Germany, Ukraine, Poland, Iraq, India, the United Kingdom, Japan, Turkey, and internationally. Rossmax International Ltd. was founded in 1988 and is based in Taipei, Taiwan.

優盛（4121）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
34.38%
Net Margin
-0.79%
Revenue Growth (YoY)
-1.34%
Profit Growth (YoY)
-2.13%
3-Year Revenue Growth
-3.59%
3-Year Profit Growth
-3.84%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
34.38%
Net Margin
-0.79%
Revenue Growth (YoY)
-1.34%
Profit Growth (YoY)
-2.13%
3-Year Revenue Growth
-3.59%
3-Year Profit Growth
-3.84%
default symbol

4121

優盛

19.45D

-2.57%

(-0.03)

  • When is 4121's latest earnings report released?

    The most recent financial report for 優盛 (4121) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4121's short-term business performance and financial health. For the latest updates on 4121's earnings releases, visit this page regularly.

  • What is the operating profit of 4121?

    According to the latest financial report, 優盛 (4121) reported an Operating Profit of -28.59M with an Operating Margin of -3.01% this period, representing a growth of 19.15% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4121's revenue growth?

    In the latest financial report, 優盛 (4121) announced revenue of 950.93M, with a Year-Over-Year growth rate of -1.93%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4121 have?

    At the end of the period, 優盛 (4121) held Total Cash and Cash Equivalents of 613.7M, accounting for 0.15 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4121 go with three margins increasing?

    In the latest report, 優盛 (4121) did not achieve the “three margins increasing” benchmark, with a gross margin of 33.58%%, operating margin of -3.01%%, and net margin of -2.2%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4121's profit trajectory and future growth potential.

  • Is 4121's EPS continuing to grow?

    According to the past four quarterly reports, 優盛 (4121)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.08. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4121?

    優盛 (4121)'s Free Cash Flow (FCF) for the period is 52.42M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 8.27% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.